Right heart thrombi (RHT) and clot in transit with concomitant PE management: Approach and considerations

Pulm Circ. 2022 Apr 25;12(2):e12080. doi: 10.1002/pul2.12080. eCollection 2022 Apr.

Abstract

Right heart thrombi (RHT) continues to pose a clinical dilemma for multiple specialties and is especially concerning when present with concomitant pulmonary embolism (PE). Patients with PE and RHT are at an increased risk of poor outcomes compared to PE without RHT. Although the exact incidence of RHT is unknown, the increasing use of point-of-care ultrasound may lead to an increased detection and frequency of RHT. There are multiple treatment strategies available for RHT, including anticoagulation, systemic thrombolysis, and endovascular and surgical therapies. Given that these treatment strategies involve multiple medical specialties, the management of RHT with concomitant PE can be complex. Currently, there is limited clinical data and guidelines on the treatment and management of RHT. We aim to provide a review on RHT with concomitant PE, including risk stratification, treatment considerations, and our approach to the management of RHT.

Keywords: pulmonary embolism (PE); right heart thrombi (RHT); thrombectomy; thrombolytic therapy.

Publication types

  • Review